Potential Side Effects, Contraindications, and Safety Questions GLP-1 medications have a well-documented safety profile, and it's worth knowing it before you start - not after your first injection
McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM (2015) Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management
The FDA provides links to large-scale studies, including the Nurses Health Study II and the Boston Birth Cohort that have results that suggest concerns
A precise reading of the published trial literature on this triple GIP/GLP-1/glucagon agonist including what happens when treatment stops
By focusing on both physical and emotional well-being, we help regulate appetite, boost energy levels, and build lasting confidence